Corvus Pharmaceuticals Cash Flow Statement (2015-2026) | CRVS

Cash Flow Statement Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-11.29M-9.05M-6.81M-7.41M-7.01M-12.47M-5.67M-6.14M-5.22M-5.13M-5.25M-5.94M-3.69M-39.53M-9.94M15.73M-7.61M-9.83M-11.61M-13.09M
Depreciation and Depletion (Quarter)
Share-based Compensation (Quarter)
1.17M1.10M0.74M0.74M0.68M0.66M0.62M0.49M0.54M0.55M0.57M0.69M0.77M0.73M0.81M1.25M1.26M1.25M1.57M2.65M
Gains from Investment Securities (Quarter)
0.11M1.41M1.14M0.65M0.18M1.70M-0.98M0.12M0.97M0.22M-1.03M0.03M0.53M0.08M2.35M11.58M-2.01M5.60M0.66M
Cash from Operations (Quarter)
-12.65M-8.43M-6.84M-6.42M-6.12M-6.93M-7.55M-8.11M-5.22M-5.43M-5.17M-5.16M-5.48M-6.32M-8.46M-8.26M-5.78M-9.57M-9.19M-10.37M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.07M0.04M0.03M0.06M0.04M-0.08M0.16M0.26M0.26M0.24M0.13M0.15M0.22M0.52M0.24M0.29M0.33M0.46M0.26M0.02M
Depreciation & Amortization (CF) (Quarter)
0.12M0.11M0.09M0.09M0.09M0.09M0.09M0.06M0.04M0.03M0.03M0.02M0.02M0.02M0.02M0.02M0.03M0.03M0.03M0.03M
Change in Working Capital
Change in Receivables (Quarter)
0.27M0.23M-0.13M0.13M0.09M-0.16M-0.43M0.01M0.01M0.04M0.01M0.00M0.01M-0.05M0.01M0.01M
Change in Account Payables (Quarter)
-2.04M-0.53M-0.77M0.62M0.21M1.83M-2.25M-0.57M0.69M-0.69M0.12M0.08M-0.40M0.66M0.71M-1.27M1.83M-1.16M0.52M2.21M
Change in Accured Expenses (Quarter)
0.45M-0.39M-0.88M-1.09M0.39M2.20M-1.02M-1.93M-1.16M0.10M-0.59M0.10M0.23M-0.09M-0.49M0.15M1.14M0.71M0.77M0.50M
Other Working Capital Changes (Quarter)
1.82M2.40M1.85M-0.30M0.82M0.26M-0.88M0.30M0.30M-0.64M0.05M-0.33M-0.34M0.84M0.38M-1.17M1.13M-1.11M0.20M0.86M
Investing Activities
Capital Expenditures (Quarter)
0.27M0.03M0.04M0.11M0.03M0.09M
Change in Acquisitions & Divestments (Quarter)
16.63M3.62M2.50M0.81M6.18M20.77M15.40M17.73M16.43M19.36M9.11M4.62M8.79M14.95M14.27M11.99M19.29M28.53M24.32M16.98M
Cash from Investing Activities (Quarter)
15.24M3.47M-2.00M-25.57M3.14M3.04M-3.88M4.60M-4.29M17.55M-2.32M-0.01M-17.50M-3.89M-6.08M4.24M-20.30M-2.62M10.88M-144.85M
Financing Activities
Cash from Financing Activities (Quarter)
11.22M18.33M0.02M0.00M7.52M0.34M0.05M18.61M0.28M35.77M0.36M0.02M190.75M
Additional items
Change in Cash (Quarter)
13.81M13.38M-8.84M-32.00M-2.98M-3.89M-11.43M-3.50M-2.00M12.45M-7.49M-5.16M7.38M-10.16M4.06M-3.74M9.69M-11.82M1.71M35.53M
Free Cash Flow (Quarter)
-12.65M-8.43M-6.84M-6.42M-6.12M-7.19M-7.55M-8.14M-5.22M-5.43M-5.17M-5.16M-5.48M-6.32M-8.46M-8.30M-5.89M-9.57M-9.22M-10.46M
Net Cash Flow (Quarter)
13.81M13.38M-8.82M-32.00M-2.98M-3.89M-11.43M-3.50M-2.00M12.45M-7.49M-5.16M-22.98M-10.16M4.06M-3.74M9.69M-11.82M1.71M35.53M